Skip to search formSkip to main contentSkip to account menu

Nadolol

Known as: 2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, Nadolol [Chemical/Ingredient] 
A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1985
1985
Summary: Various antihypertensive agents were studied in vitro to determine their effects on cholesterol esterification by… 
1985
1985
Recent observations on sympathetic constriction of the poststenotic coronary bed without dilatory reserve indicate the… 
1985
1985
Recently a medical treatment with propranolol has been proposed in order to decrease portal pressure and lessen the risk of… 
1984
1984
  • A. SchiffA. Saxey
  • 1984
  • Corpus ID: 29776088
Whole-body autoradiography of rats dosed with [14C]propranolol or [14C]nadolol have confirmed physicochemical predictions that… 
1984
1984
A reverse-phase high-performance liquid chromatographic (HPLC) method was developed for the simultaneous assay of nadolol and… 
1983
1983
The anti-arrhythmic efficacy of sotalol, a beta-blocking agent which possesses class III anti-arrhythmic properties, was compared… 
1981
1981
Nadolol, a new nonselective beta 1 and beta 2 adrenergic blocking agent, has a plasma half-life of 17 to 23 hours. We studied 37… 
1978
1978
A method to determine the serum concentration of the beta-adrenergic receptor blocking agent, nadolol, by GLC--selected ion… 
1978
1978
A preliminary, single-blind, dose-ranging study was carried out in 30 patients with essential hypertension to assess the efficacy…